Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia
Gespeichert in:
| Veröffentlicht in: | European journal of clinical microbiology & infectious diseases 2001-01, Vol.20 (1), p.73-75 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 75 |
|---|---|
| container_issue | 1 |
| container_start_page | 73 |
| container_title | European journal of clinical microbiology & infectious diseases |
| container_volume | 20 |
| creator | TRIPODI, M. F ANDREANA, A SARNATARO, G RAGONE, E ADINOLFI, L. E UTILI, R |
| description | |
| doi_str_mv | 10.1007/PL00011239 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17809956</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17809956</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-de9bff9bbc0b6a36abbe9d0743d4bdc2466486b404888b07a7e1eb0bc4c3bffa3</originalsourceid><addsrcrecordid>eNpdkd2KFDEQhYMo7rh64wNIUPBCbE06mU7nchn8gwEF9bqppKudWruTNsn48zS-qll3cMGrU5X66lDhMPZQihdSCPPyw14IIWWr7C22kVptG62Mus02wirdWNOqM3Yv58tKmd6Yu-yswnqrlNqw37u4rJCg0Hfk4KtQIcw8TpwyrrCQp_CcV_0KfyuPE660YH0LI_e0pjjN8efVkMMcA_KYeK19XByF6hsD_0HlwGM5YKpLhRzFQj5z-AIUcuEfC4ZYUlwPcYkBMl9gLrWjmeA-uzPBnPHBSc_Z59evPu3eNvv3b97tLvaNV50tzYjWTZN1zgvXgerAObSjMFqN2o2-1V2n-85pofu-d8KAQYlOOK-9qougztnTa9_6n29HzGVYKHucZwgYj3mQphfWbrsKPv4PvIzHFOptQ2-kkHbb9hV6dg35FHNOOA1rogXSr0GK4Sqz4SazCj86OR7dguMNegqpAk9OAGQP85QgeMr_OCtaK7bqDzwPomY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>871019528</pqid></control><display><type>article</type><title>Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>TRIPODI, M. F ; ANDREANA, A ; SARNATARO, G ; RAGONE, E ; ADINOLFI, L. E ; UTILI, R</creator><creatorcontrib>TRIPODI, M. F ; ANDREANA, A ; SARNATARO, G ; RAGONE, E ; ADINOLFI, L. E ; UTILI, R</creatorcontrib><identifier>ISSN: 0934-9723</identifier><identifier>EISSN: 1435-4373</identifier><identifier>DOI: 10.1007/PL00011239</identifier><identifier>PMID: 11245333</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; amikacin ; Amikacin - pharmacology ; Amikacin - therapeutic use ; Anti-Bacterial Agents - pharmacology ; Anti-Bacterial Agents - therapeutic use ; Anti-Infective Agents - pharmacology ; Anti-Infective Agents - therapeutic use ; Antibacterial agents ; Antibiotics ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cefepime ; Cephalosporins - pharmacology ; Cephalosporins - therapeutic use ; ciprofloxacin ; Ciprofloxacin - pharmacology ; Ciprofloxacin - therapeutic use ; Colony Count, Microbial ; Drug Resistance, Bacterial ; Drug Resistance, Multiple, Bacterial ; Drug Synergism ; Drug Therapy, Combination ; Gentamicins - pharmacology ; Gentamicins - therapeutic use ; Gram-Negative Bacterial Infections - drug therapy ; Gram-Negative Bacterial Infections - microbiology ; HIV ; Human immunodeficiency virus ; Immune system ; Infections ; Infectious diseases ; isepamicin ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Pneumonia ; Stenotrophomonas maltophilia ; Stenotrophomonas maltophilia - drug effects ; Time Factors</subject><ispartof>European journal of clinical microbiology & infectious diseases, 2001-01, Vol.20 (1), p.73-75</ispartof><rights>2001 INIST-CNRS</rights><rights>Springer-Verlag Berlin Heidelberg 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-de9bff9bbc0b6a36abbe9d0743d4bdc2466486b404888b07a7e1eb0bc4c3bffa3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=902905$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11245333$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TRIPODI, M. F</creatorcontrib><creatorcontrib>ANDREANA, A</creatorcontrib><creatorcontrib>SARNATARO, G</creatorcontrib><creatorcontrib>RAGONE, E</creatorcontrib><creatorcontrib>ADINOLFI, L. E</creatorcontrib><creatorcontrib>UTILI, R</creatorcontrib><title>Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia</title><title>European journal of clinical microbiology & infectious diseases</title><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>amikacin</subject><subject>Amikacin - pharmacology</subject><subject>Amikacin - therapeutic use</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Anti-Infective Agents - pharmacology</subject><subject>Anti-Infective Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cefepime</subject><subject>Cephalosporins - pharmacology</subject><subject>Cephalosporins - therapeutic use</subject><subject>ciprofloxacin</subject><subject>Ciprofloxacin - pharmacology</subject><subject>Ciprofloxacin - therapeutic use</subject><subject>Colony Count, Microbial</subject><subject>Drug Resistance, Bacterial</subject><subject>Drug Resistance, Multiple, Bacterial</subject><subject>Drug Synergism</subject><subject>Drug Therapy, Combination</subject><subject>Gentamicins - pharmacology</subject><subject>Gentamicins - therapeutic use</subject><subject>Gram-Negative Bacterial Infections - drug therapy</subject><subject>Gram-Negative Bacterial Infections - microbiology</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>isepamicin</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Pneumonia</subject><subject>Stenotrophomonas maltophilia</subject><subject>Stenotrophomonas maltophilia - drug effects</subject><subject>Time Factors</subject><issn>0934-9723</issn><issn>1435-4373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkd2KFDEQhYMo7rh64wNIUPBCbE06mU7nchn8gwEF9bqppKudWruTNsn48zS-qll3cMGrU5X66lDhMPZQihdSCPPyw14IIWWr7C22kVptG62Mus02wirdWNOqM3Yv58tKmd6Yu-yswnqrlNqw37u4rJCg0Hfk4KtQIcw8TpwyrrCQp_CcV_0KfyuPE660YH0LI_e0pjjN8efVkMMcA_KYeK19XByF6hsD_0HlwGM5YKpLhRzFQj5z-AIUcuEfC4ZYUlwPcYkBMl9gLrWjmeA-uzPBnPHBSc_Z59evPu3eNvv3b97tLvaNV50tzYjWTZN1zgvXgerAObSjMFqN2o2-1V2n-85pofu-d8KAQYlOOK-9qougztnTa9_6n29HzGVYKHucZwgYj3mQphfWbrsKPv4PvIzHFOptQ2-kkHbb9hV6dg35FHNOOA1rogXSr0GK4Sqz4SazCj86OR7dguMNegqpAk9OAGQP85QgeMr_OCtaK7bqDzwPomY</recordid><startdate>20010101</startdate><enddate>20010101</enddate><creator>TRIPODI, M. F</creator><creator>ANDREANA, A</creator><creator>SARNATARO, G</creator><creator>RAGONE, E</creator><creator>ADINOLFI, L. E</creator><creator>UTILI, R</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7T7</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20010101</creationdate><title>Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia</title><author>TRIPODI, M. F ; ANDREANA, A ; SARNATARO, G ; RAGONE, E ; ADINOLFI, L. E ; UTILI, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-de9bff9bbc0b6a36abbe9d0743d4bdc2466486b404888b07a7e1eb0bc4c3bffa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>amikacin</topic><topic>Amikacin - pharmacology</topic><topic>Amikacin - therapeutic use</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Anti-Infective Agents - pharmacology</topic><topic>Anti-Infective Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cefepime</topic><topic>Cephalosporins - pharmacology</topic><topic>Cephalosporins - therapeutic use</topic><topic>ciprofloxacin</topic><topic>Ciprofloxacin - pharmacology</topic><topic>Ciprofloxacin - therapeutic use</topic><topic>Colony Count, Microbial</topic><topic>Drug Resistance, Bacterial</topic><topic>Drug Resistance, Multiple, Bacterial</topic><topic>Drug Synergism</topic><topic>Drug Therapy, Combination</topic><topic>Gentamicins - pharmacology</topic><topic>Gentamicins - therapeutic use</topic><topic>Gram-Negative Bacterial Infections - drug therapy</topic><topic>Gram-Negative Bacterial Infections - microbiology</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>isepamicin</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Pneumonia</topic><topic>Stenotrophomonas maltophilia</topic><topic>Stenotrophomonas maltophilia - drug effects</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TRIPODI, M. F</creatorcontrib><creatorcontrib>ANDREANA, A</creatorcontrib><creatorcontrib>SARNATARO, G</creatorcontrib><creatorcontrib>RAGONE, E</creatorcontrib><creatorcontrib>ADINOLFI, L. E</creatorcontrib><creatorcontrib>UTILI, R</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>European journal of clinical microbiology & infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TRIPODI, M. F</au><au>ANDREANA, A</au><au>SARNATARO, G</au><au>RAGONE, E</au><au>ADINOLFI, L. E</au><au>UTILI, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia</atitle><jtitle>European journal of clinical microbiology & infectious diseases</jtitle><addtitle>Eur J Clin Microbiol Infect Dis</addtitle><date>2001-01-01</date><risdate>2001</risdate><volume>20</volume><issue>1</issue><spage>73</spage><epage>75</epage><pages>73-75</pages><issn>0934-9723</issn><eissn>1435-4373</eissn><cop>Berlin</cop><pub>Springer</pub><pmid>11245333</pmid><doi>10.1007/PL00011239</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0934-9723 |
| ispartof | European journal of clinical microbiology & infectious diseases, 2001-01, Vol.20 (1), p.73-75 |
| issn | 0934-9723 1435-4373 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_17809956 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Acquired immune deficiency syndrome AIDS amikacin Amikacin - pharmacology Amikacin - therapeutic use Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Anti-Infective Agents - pharmacology Anti-Infective Agents - therapeutic use Antibacterial agents Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cefepime Cephalosporins - pharmacology Cephalosporins - therapeutic use ciprofloxacin Ciprofloxacin - pharmacology Ciprofloxacin - therapeutic use Colony Count, Microbial Drug Resistance, Bacterial Drug Resistance, Multiple, Bacterial Drug Synergism Drug Therapy, Combination Gentamicins - pharmacology Gentamicins - therapeutic use Gram-Negative Bacterial Infections - drug therapy Gram-Negative Bacterial Infections - microbiology HIV Human immunodeficiency virus Immune system Infections Infectious diseases isepamicin Medical sciences Microbial Sensitivity Tests Pharmacology. Drug treatments Pneumonia Stenotrophomonas maltophilia Stenotrophomonas maltophilia - drug effects Time Factors |
| title | Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T14%3A33%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparative%20activities%20of%20isepamicin,%20amikacin,%20cefepime,%20and%20ciprofloxacin%20alone%20or%20in%20combination%20with%20other%20antibiotics%20against%20Stenotrophomonas%20maltophilia&rft.jtitle=European%20journal%20of%20clinical%20microbiology%20&%20infectious%20diseases&rft.au=TRIPODI,%20M.%20F&rft.date=2001-01-01&rft.volume=20&rft.issue=1&rft.spage=73&rft.epage=75&rft.pages=73-75&rft.issn=0934-9723&rft.eissn=1435-4373&rft_id=info:doi/10.1007/PL00011239&rft_dat=%3Cproquest_cross%3E17809956%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=871019528&rft_id=info:pmid/11245333&rfr_iscdi=true |